Total Visits

Views
The Proteasome Inhibitor Bortezomib Sensitizes AML with Myelomonocytic Differentiation to TRAIL Mediated Apoptosis703

Total Visits Per Month

February 2016March 2016April 2016May 2016June 2016July 2016August 2016
The Proteasome Inhibitor Bortezomib Sensitizes AML with Myelomonocytic Differentiation to TRAIL Mediated Apoptosis3111161

File Visits

Views
cancers-03-01329.pdf655
license.txt63
sword-2012-02-16.original2

Top country views

Views
United States339
China85
Ireland70
Germany26
Russia16
Japan14
Netherlands14
United Kingdom11
France8
Belarus7

Top cities views

Views
Cleveland66
Mountain View56
Woodbridge42
Oranmore39
Sunnyvale35
Beijing30
Gaillimh20
Seattle11
Kiez8
Leipzig8